Prodia Widyahusada Tbk PT (PRDA) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.073x

Based on the latest financial reports, Prodia Widyahusada Tbk PT (PRDA) has a cash flow conversion efficiency ratio of 0.073x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp169.15 Billion ≈ $9.91 Million USD) by net assets (Rp2.31 Trillion ≈ $135.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Prodia Widyahusada Tbk PT net asset quality index to measure how much of total assets are equity-financed.

Prodia Widyahusada Tbk PT - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Prodia Widyahusada Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Prodia Widyahusada Tbk PT cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Prodia Widyahusada Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Prodia Widyahusada Tbk PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
China Silver Group Limited
F:2CS
0.013x
Thailand Prime Property Freehold and Leasehold Real Estate Investment Trust
BK:TPRIME
0.018x
Raj Rayon Industries Limited
NSE:RAJRILTD
0.604x
Chosun Refractories Co Ltd
KO:000480
0.032x
Alicon Castalloy Limited
NSE:ALICON
0.185x
GalaxiaMoneytree Co.Ltd
KQ:094480
-0.044x
Graphite One Inc
V:GPH
-0.057x
Financiera Independencia S.A.B. de C.V. SOFOM E.N.R
MX:FINDEP
0.097x

Annual Cash Flow Conversion Efficiency for Prodia Widyahusada Tbk PT (2013–2024)

The table below shows the annual cash flow conversion efficiency of Prodia Widyahusada Tbk PT from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see PRDA company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp2.48 Trillion
≈ $145.59 Million
Rp476.64 Billion
≈ $27.93 Million
0.192x +10.10%
2023-12-31 Rp2.36 Trillion
≈ $138.32 Million
Rp411.29 Billion
≈ $24.10 Million
0.174x -18.94%
2022-12-31 Rp2.31 Trillion
≈ $135.42 Million
Rp496.73 Billion
≈ $29.11 Million
0.215x -37.72%
2021-12-31 Rp2.25 Trillion
≈ $131.98 Million
Rp777.27 Billion
≈ $45.54 Million
0.345x +41.99%
2020-12-31 Rp1.79 Trillion
≈ $104.79 Million
Rp434.63 Billion
≈ $25.47 Million
0.243x +18.00%
2019-12-31 Rp1.66 Trillion
≈ $97.25 Million
Rp341.82 Billion
≈ $20.03 Million
0.206x +34.16%
2018-12-31 Rp1.56 Trillion
≈ $91.54 Million
Rp239.83 Billion
≈ $14.05 Million
0.154x +123.89%
2017-12-31 Rp1.36 Trillion
≈ $79.87 Million
Rp93.47 Billion
≈ $5.48 Million
0.069x -27.13%
2016-12-31 Rp1.27 Trillion
≈ $74.26 Million
Rp119.25 Billion
≈ $6.99 Million
0.094x -92.36%
2015-12-31 Rp126.33 Billion
≈ $7.40 Million
Rp155.61 Billion
≈ $9.12 Million
1.232x +56.52%
2014-12-31 Rp134.25 Billion
≈ $7.87 Million
Rp105.66 Billion
≈ $6.19 Million
0.787x -15.91%
2013-12-31 Rp88.32 Billion
≈ $5.18 Million
Rp82.66 Billion
≈ $4.84 Million
0.936x --

About Prodia Widyahusada Tbk PT

JK:PRDA Indonesia Diagnostics & Research
Market Cap
$131.29 Million
Rp2.24 Trillion IDR
Market Cap Rank
#18190 Global
#288 in Indonesia
Share Price
Rp2390.00
Change (1 day)
+0.84%
52-Week Range
Rp2300.00 - Rp2850.00
All Time High
Rp8245.29
About

PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia specialty clinics; and offers vaccination, doctor consultation, and home services. It serves to individuals, doctors, and corporate and partnerships. The company was founded in 1973 and is headquartered in … Read more